Furthermore, decreased levels of Mcm2 as a sign of dysregulated cell cycle progression has been shown in hepatocytes in NAFLD (Dabravolski et al., 2021). Here, MCM2 is linked to metabolic dysfunction-associated steatotic liver disease.